Vanguard Group Inc Eagle Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Eagle Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 579,507 shares of EGRX stock, worth $376,679. This represents 0.0% of its overall portfolio holdings.

Number of Shares

579,507

Previous 564,396 2.68%

Holding current value

$376,679

Previous $3.16 Million 31.99%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$3.71 - $6.07 $56,061 - $91,723	15,111 Added 2.68%	579,507 $2.15 Million
Q2 2024 Aug 13, 2024	SELL	$3.34 - $5.6 $255,035 - $427,604	-76,358 Reduced 11.92%	564,396 $3.16 Million
Q1 2024 May 10, 2024	BUY	$4.26 - $6.51 $11,203 - $17,121	2,630 Added 0.41%	640,754 $3.36 Million
Q4 2023 Feb 14, 2024	SELL	$4.63 - $15.21 $25,339 - $83,244	-5,473 Reduced 0.85%	638,124 $3.34 Million
Q3 2023 Nov 14, 2023	BUY	$15.21 - $22.88 $333,266 - $501,323	21,911 Added 3.52%	643,597 $10.1 Million
Q2 2023 Aug 14, 2023	SELL	$17.74 - $31.87 $2.4 Million - $4.3 Million	-135,046 Reduced 17.85%	621,686 $12.1 Million
Q1 2023 May 15, 2023	SELL	$25.06 - $34.09 $177,299 - $241,186	-7,075 Reduced 0.93%	756,732 $21.5 Million
Q4 2022 Feb 10, 2023	SELL	$24.98 - $39.77 $292,465 - $465,627	-11,708 Reduced 1.51%	763,807 $22.3 Million
Q3 2022 Nov 14, 2022	BUY	$26.42 - $47.12 $99,233 - $176,982	3,756 Added 0.49%	775,515 $20.5 Million
Q2 2022 Aug 12, 2022	SELL	$41.26 - $51.35 $375,135 - $466,874	-9,092 Reduced 1.16%	771,759 $34.3 Million
Q1 2022 May 13, 2022	BUY	$44.58 - $52.6 $908,674 - $1.07 Million	20,383 Added 2.68%	780,851 $38.6 Million
Q4 2021 Feb 14, 2022	SELL	$45.82 - $56.9 $119,040 - $147,826	-2,598 Reduced 0.34%	760,468 $38.7 Million
Q3 2021 Nov 12, 2021	BUY	$43.79 - $55.78 $428,528 - $545,863	9,786 Added 1.3%	763,066 $42.6 Million
Q2 2021 Aug 13, 2021	BUY	$36.86 - $44.5 $27.8 Million - $33.5 Million	753,280 New	753,280 $32.2 Million

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.59M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $8.46M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Eagle Pharmaceuticals, Inc. Transaction History